Prioritizing cefuroxime as empirical treatment in acute bacterial prostatitis: patient characteristics and outcome
Empirical intravenous cefuroxime followed by oral step-down appears safe and effective for ABP, especially in the absence of known risk factors for resistant pathogens. These findings support fluoroquinolone-sparing approaches in empiric UTI management, tailored to local microbiological profiles and individual comorbidities.
Authors
- Grégoire Wieërs (ORCID: https://orcid.org/0000-0001-7540-8068)
- Valérie Verbelen
- Antoine Christiaens (ORCID: https://orcid.org/0000-0002-4132-7769)
- Louise Doyen
- Jean-Christophe Marot
- Emilien Lecomte
- Martin Arys
Institutions
- University of Namur (BE)
- Clinique Saint Pierre (BE)
- UCLouvain (BE)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1093/jacamr/dlaf250
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00